Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Menopause affects hair and skin; more research needed for treatment.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.